GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Medicover AB (FRA:5M0B) » Definitions » Research & Development

Medicover AB (FRA:5M0B) Research & Development : €0 Mil (TTM As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Medicover AB Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Medicover AB's Research & Development for the three months ended in Jun. 2024 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 was €0 Mil.


Medicover AB Research & Development Historical Data

The historical data trend for Medicover AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicover AB Research & Development Chart

Medicover AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Medicover AB Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Medicover AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medicover AB  (FRA:5M0B) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Medicover AB Research & Development Related Terms

Thank you for viewing the detailed overview of Medicover AB's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicover AB Business Description

Traded in Other Exchanges
Address
Riddargatan 12A, P.O. Box 5283, Stockholm, SWE, SE-102 46
Medicover AB is an international healthcare and diagnostic services, provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. The company offers its services through two segments; Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas in Germany, Romania, Poland, and Ukraine, and Healthcare Services offer high-quality care based on an Integrated Healthcare Model and Fee-For-Service in Poland, India, and Romania. It generates maximum revenue from the Healthcare Services segment. Geographically, it derives a majority of its revenue from Poland and also has a presence in Romania; Germany; Ukraine; India, and Other Countries.

Medicover AB Headlines

No Headlines